Evaluation of the Effect of Carbamazepine on the Steady-State Pharmacokinetics of Paliperidone Extended Release in Clinically Stable Subjects With Schizophrenia or Bipolar I Disorder.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Carbamazepine; Paliperidone
- Indications Bipolar I disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 04 Aug 2009 Actual patient number (64) added as reported by ClinicalTrials.gov.
- 14 May 2009 New trial record